Entries by connective

NanoString Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

Empowering researchers to spatially profile more than 500 proteins simultaneously in FFPE tissue using abcam’s IHC-validated immuno-oncology antibody portfolio Seattle, September 13, 2023 – (BUSINESS WIRE) — NanoString Technologies, a leading provider of life science tools for discovery and translational research, announced today the launch of the latest assay for the GeoMx® Digital Spatial Profiler […]

Interim results for the six-month period ended 30 June 2023

31 August 2023, Cambridge, UK / Waltham, MA – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ended 30 June 2023 (the ‘period’). Download full press release (pdf)

Danaher to acquire Abcam for $24.00 per Share

Cambridge, UK / Waltham, MA, August 28, 2023 – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, announced today that it has entered into a definitive agreement pursuant to which Danaher Corporation (NYSE: DHR) (‘Danaher’) will acquire all of the outstanding shares […]

All Resolutions Withdrawn at Abcam’s EGM

CAMBRIDGE, England and WALTHAM, Mass., July 12, 2023 – Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today held an Extraordinary General Meeting of its shareholders (the “EGM”) that was convened following a requisition notice from Dr. Jonathan Milner dated May 30, 2023 (the “Requisition […]

Trading Update

Cambridge, UK: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following preliminary trading update for the half ending 30 June 2023. Preliminary results Period Estimated Reported Revenue Estimated Adjusted Operating Profit % H1 2023 >£203 million >26% First half 2023 estimated revenues […]

Abcam plc: FY2024 Guidance

CAMBRIDGE, England and WALTHAM, Mass. — Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today provides the following updates. Although the Company acknowledges that these financial updates are being provided outside our normal reporting cycles, the Board and management team believe that it is in […]

Abcam Announces Review of Strategic Alternatives

Cambridge, UK / Waltham, MA: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that, having listened to and extensively engaged with shareholders, the Board of Directors has unanimously decided to initiate a process to explore strategic alternatives for the Company. The comprehensive process […]

Abcam highlights successful execution of strategic priorities to drive shareholder value

Files investor presentation; urges shareholders to vote AGAINST all resolutions at July 12 EGM Under CEO Alan Hirzel’s leadership, Abcam has transformed as a business, created significant value for all stakeholders, and outperformed the market The Company is on track to deliver its 2024 revenue and profit margin goals Abcam’s strong, independent, and highly qualified […]

Abcam plc files and mails Shareholder Circular calling an Extraordinary General Meeting

Highlights progress in delivering on long-term plan and outlines attempts to engage constructively with Dr. Jonathan Milner Asks shareholders to support the Company and vote “AGAINST” all resolutions to be proposed at the EGM CAMBRIDGE, England and WALTHAM, Mass., June 16, 2023 /PRNewswire/ — Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in […]